{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:58:41Z","timestamp":1790193521200,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10620-024-08710-4","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T17:10:44Z","timestamp":1736356244000},"page":"1052-1063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["From Endoscopic Inspection to Gene-Expression: A Thorough Assessment of the Duodenal Mucosa After Resurfacing\u2014A Prospective Study"],"prefix":"10.1007","volume":"70","author":[{"given":"S.","family":"Meiring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6.","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C. G.","family":"van Baar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. W. J.","family":"van der Vossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rampanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. C. T.","family":"van Grieken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Holleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nieuwdorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J. G. H. M.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"8710_CR1","unstructured":"International Diabetes F. IDF Diabetes Atlas. Ninth edition ed. www.diabetesatlas.org, 2019."},{"key":"8710_CR2","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/S0140-6736(15)00075-6","volume":"386","author":"G Mingrone","year":"2015","unstructured":"Mingrone G, Panunzi S, De Gaetano A et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 2015;386:964\u2013973.","journal-title":"Lancet"},{"key":"8710_CR3","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1053\/j.gastro.2012.01.034","volume":"142","author":"S Pendyala","year":"2012","unstructured":"Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 2012;142:e2.","journal-title":"Gastroenterology"},{"key":"8710_CR4","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani PD, Amar J, Iglesias MA et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761\u20131772.","journal-title":"Diabetes"},{"key":"8710_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.gastro.2018.02.010","volume":"154","author":"ACG van Baar","year":"2018","unstructured":"van Baar ACG, Nieuwdorp M, Holleman F et al. The Duodenum harbors a Broad Untapped Therapeutic Potential. Gastroenterology 2018;154:773\u2013777.","journal-title":"Gastroenterology"},{"key":"8710_CR6","first-page":"912","volume":"76","author":"MA Nauck","year":"1993","unstructured":"Nauck MA, Bartels E, Orskov C et al. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7\u201336) amide infused at near-physiological insulinotropic hormone and glucose concentrations. J Clin Endocrinol Metab 1993;76:912\u2013917.","journal-title":"J Clin Endocrinol Metab"},{"key":"8710_CR7","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s00125-003-1103-y","volume":"46","author":"JJ Meier","year":"2003","unstructured":"Meier JJ, Gallwitz B, Siepmann N et al. Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia. Diabetologia 2003;46:798\u2013801.","journal-title":"Diabetologia"},{"key":"8710_CR8","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1210\/jcem-24-10-1076","volume":"24","author":"H Elrick","year":"1964","unstructured":"Elrick H, Stimmler L, Hlad CJ Jr et al. Plasma Insulin Response to Oral and Intravenous Glucose Administration. J Clin Endocrinol Metab 1964;24:1076\u20131082.","journal-title":"J Clin Endocrinol Metab"},{"key":"8710_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/379069a0","volume":"379","author":"MD Turton","year":"1996","unstructured":"Turton MD, O\u2019Shea D, Gunn I et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996;379:69\u201372.","journal-title":"Nature"},{"key":"8710_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1172\/JCI990","volume":"101","author":"A Flint","year":"1998","unstructured":"Flint A, Raben A, Astrup A et al. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 1998;101:515\u2013520.","journal-title":"J Clin Invest"},{"key":"8710_CR11","doi-asserted-by":"crossref","unstructured":"N. van Olst SMea. Small intestinall physiology relevant to bariatric and metabolic endoscopic therapies: Incretins, bile acid signalling, and gut microbiome Volume 22. Techniques and Innovations Gastrointestinal Endoscopy 2020:109\u2013119.","DOI":"10.1016\/j.tige.2020.03.003"},{"key":"8710_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2337\/dc11-1472","volume":"35","author":"BJ Van der Schueren","year":"2012","unstructured":"Van der Schueren BJ, Homel P, Alam M et al. Magnitude and variability of the glucagon-like peptide-1 response in patients with type 2 diabetes up to 2 years following gastric bypass surgery. Diabetes Care 2012;35:42\u201346.","journal-title":"Diabetes Care"},{"key":"8710_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2337\/dc16-1376","volume":"40","author":"MM Holter","year":"2017","unstructured":"Holter MM, Dutia R, Stano SM et al. Glucose Metabolism After Gastric Banding and Gastric Bypass in Individuals With Type 2 Diabetes: Weight Loss Effect. Diabetes Care 2017;40:7\u201315.","journal-title":"Diabetes Care"},{"key":"8710_CR14","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1113\/JP270264","volume":"593","author":"MT Lund","year":"2015","unstructured":"Lund MT, Hansen M, Skaaby S et al. Preoperative beta-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery. J Physiol 2015;593:3123\u20133133.","journal-title":"J Physiol"},{"key":"8710_CR15","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1210\/jc.2007-2851","volume":"93","author":"B Laferrere","year":"2008","unstructured":"Laferrere B, Teixeira J, McGinty J et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008;93:2479\u20132485.","journal-title":"J Clin Endocrinol Metab"},{"key":"8710_CR16","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1007\/s00125-018-4553-y","volume":"61","author":"JQ Purnell","year":"2018","unstructured":"Purnell JQ, Johnson GS, Wahed AS et al. Prospective evaluation of insulin and incretin dynamics in obese adults with and without diabetes for 2 years after Roux-en-Y gastric bypass. Diabetologia 2018;61:1142\u20131154.","journal-title":"Diabetologia"},{"key":"8710_CR17","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.2337\/dc16-0383","volume":"39","author":"H Rajagopalan","year":"2016","unstructured":"Rajagopalan H, Cherrington AD, Thompson CC et al. Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study. Diabetes Care 2016;39:2254\u20132261.","journal-title":"Diabetes Care"},{"key":"8710_CR18","doi-asserted-by":"crossref","unstructured":"van Baar ACG, Holleman F, Crenier L, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study. Gut 2019.","DOI":"10.1136\/gutjnl-2019-318349"},{"key":"8710_CR19","unstructured":"Bergman J, Deviere J, Hopkins D. Abstract: Topline results from REVITA-2: The first randomized, double-blind, sham-controlled, prospective, multicenter study of duodenal mucosal resurfacing (DMR) efficacy, safety, and impact on NASH biomarkers in T2D: American Association for the Study of Liver Diseases 2019."},{"key":"8710_CR20","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1093\/bib\/bby067","volume":"20","author":"A McDermaid","year":"2019","unstructured":"McDermaid A, Monier B, Zhao J et al. Interpretation of differential gene expression results of RNA-seq data: review and integration. Brief Bioinform 2019;20:2044\u20132054.","journal-title":"Brief Bioinform"},{"key":"8710_CR21","doi-asserted-by":"publisher","first-page":"6491","DOI":"10.1073\/pnas.1802973116","volume":"116","author":"M Crow","year":"2019","unstructured":"Crow M, Lim N, Ballouz S et al. Predictability of human differential gene expression. Proc Natl Acad Sci U S A 2019;116:6491\u20136500.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8710_CR22","doi-asserted-by":"crossref","unstructured":"van Baar ACG, Meiring S, Smeele P, et al. Duodenal mucosal resurfacing combined with GLP-1RA to discontinue insulin in type 2 diabetes: a feasibility study. Gastrointest Endosc 2020.","DOI":"10.1016\/j.gie.2020.12.021"},{"key":"8710_CR23","doi-asserted-by":"crossref","unstructured":"Hewitson TD. Histology Protocols In: Darby IA, ed: Humana Press, 2010.","DOI":"10.1007\/978-1-60327-345-9"},{"key":"8710_CR24","doi-asserted-by":"crossref","unstructured":"Mingrone G, van Baar AC, Deviere J, et al. Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial. Gut 2021.","DOI":"10.1136\/gutjnl-2020-323608"},{"key":"8710_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13075-018-1512-4.PMID:29415757;PMCID:PMC5803867","volume":"20","author":"M Chen","year":"2018","unstructured":"Chen M, Lu X, Lu C et al. Soluble uric acid increases PDZK1 and ABCG2 expression in human intestinal cell lines via the TLR4-NLRP3 inflammasome and PI3K\/Akt signaling pathway. Arthritis Res Ther. 2018;20:20. https:\/\/doi.org\/10.1186\/s13075-018-1512-4.PMID:29415757;PMCID:PMC5803867.","journal-title":"Arthritis Res Ther."},{"key":"8710_CR26","doi-asserted-by":"publisher","first-page":"e00051","DOI":"10.1002\/edm2.51","volume":"2","author":"S Tofe","year":"2019","unstructured":"Tofe S, Arguelles I, Mena E et al. Real-world GLP-1 RA therapy in type 2 diabetes: A long-term effectiveness observational study. Endocrinol Diabetes Metab 2019;2:e00051.","journal-title":"Endocrinol Diabetes Metab"},{"key":"8710_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-230X-8-9.PMID:18405344;PMCID:PMC2323380","volume":"11","author":"H Haveri","year":"2008","unstructured":"Haveri H, Westerholm-Ormio M, Lindfors K et al. Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa. BMC Gastroenterol. 2008;11:9. https:\/\/doi.org\/10.1186\/1471-230X-8-9.PMID:18405344;PMCID:PMC2323380.","journal-title":"BMC Gastroenterol."},{"key":"8710_CR28","doi-asserted-by":"publisher","unstructured":"Nichols RG, Davenport ER. The relationship between the gut microbiome and host gene expression: a review. Hum Genet. 2021 May;140:747\u2013760. https:\/\/doi.org\/10.1007\/s00439-020-02237-0. Epub 2020 Nov 22. PMID: 33221945; PMCID: PMC7680557.","DOI":"10.1007\/s00439-020-02237-0"},{"key":"8710_CR29","doi-asserted-by":"publisher","first-page":"e0181693","DOI":"10.1371\/journal.pone.0181693","volume":"12","author":"SD Udayappan","year":"2017","unstructured":"Udayappan SD, Kovatcheva-Datchary P, Bakker GJ et al. Intestinal Ralstonia pickettii augments glucose intolerance in obesity. PLoS One 2017;12:e0181693.","journal-title":"PLoS One"},{"key":"8710_CR30","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1007\/s00125-007-0776-z","volume":"50","author":"JA Maassen","year":"2007","unstructured":"Maassen JA, Romijn JA, Heine RJ. Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus. Diabetologia 2007;50:2036\u20132041.","journal-title":"Diabetologia"},{"key":"8710_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/osp4.545","volume":"8","author":"GJ Bakker","year":"2022","unstructured":"Bakker GJ, Meijnikman AS, Scheithauer TP et al. Fecal microbiota transplantation does not alter bacterial translocation and visceral adipose tissue inflammation in individuals with obesity. Obes Sci Pract 2022;8:56\u201365.","journal-title":"Obes Sci Pract"},{"key":"8710_CR32","unstructured":"Cards G. Genecards.com."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08710-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08710-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08710-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T16:23:08Z","timestamp":1742314988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08710-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["8710"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08710-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"8 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SM, OA, AB, EV, NS, NvG, ER and MN have no conflict of interest. JB received research support from Fractyl laboratories Inc. for IRB-based studies and received a consultancy fee for a single advisory board meeting of Fractyl in September 2019. M.N. is in the scientific board of Caelus Pharmaceuticals, the Netherlands.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}